McKesson Co. (NYSE:MCK) Shares Bought by Mizuho Securities USA LLC

Mizuho Securities USA LLC boosted its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 43.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,031 shares of the company's stock after buying an additional 3,622 shares during the period. Mizuho Securities USA LLC's holdings in McKesson were worth $6,857,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of MCK. Millstone Evans Group LLC acquired a new position in McKesson in the 4th quarter valued at about $28,000. RPg Family Wealth Advisory LLC purchased a new stake in McKesson in the 3rd quarter valued at approximately $31,000. Synergy Asset Management LLC acquired a new position in McKesson during the 4th quarter worth approximately $32,000. Crews Bank & Trust acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $33,000. Finally, Atala Financial Inc acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $34,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity at McKesson

In related news, CEO Brian S. Tyler sold 8,961 shares of the firm's stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at approximately $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Leann B. Smith sold 188 shares of the company's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the transaction, the executive vice president now directly owns 1,051 shares of the company's stock, valued at $640,679.09. This trade represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,689 shares of company stock worth $11,187,351. 0.11% of the stock is currently owned by insiders.

Remove Ads

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Wells Fargo & Company raised their target price on McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a report on Friday, March 14th. Bank of America decreased their price objective on shares of McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Citigroup dropped their target price on shares of McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a report on Friday, January 10th. Evercore ISI boosted their price target on McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research note on Thursday, February 6th. Finally, StockNews.com cut McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Two research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $649.36.

McKesson Stock Performance

McKesson stock traded up $3.38 during midday trading on Thursday, reaching $666.40. 690,142 shares of the company were exchanged, compared to its average volume of 801,746. The company has a market capitalization of $83.52 billion, a price-to-earnings ratio of 30.51, a P/E/G ratio of 1.29 and a beta of 0.52. The firm's 50-day simple moving average is $620.63 and its 200-day simple moving average is $577.10. McKesson Co. has a 1 year low of $464.42 and a 1 year high of $671.58.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, analysts forecast that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be given a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date is Monday, March 3rd. McKesson's dividend payout ratio is currently 13.00%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.